134 related articles for article (PubMed ID: 35318007)
1. Rapid FEV
Lee HW; Lee HJ; Lee JK; Park TY; Heo EY; Kim DK
Chest; 2022 Aug; 162(2):466-474. PubMed ID: 35318007
[TBL] [Abstract][Full Text] [Related]
2. Rapid FEV
Choi KY; Lee HJ; Lee JK; Park TY; Heo EY; Kim DK; Lee HW
J Korean Med Sci; 2023 Jan; 38(1):e4. PubMed ID: 36593688
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort.
Lee HW; Lee JK; Lee MG; Shin KC; Ra SW; Kim TH; Hwang YI; Jung KS; Yoo KH; Kim DK
Respiration; 2022; 101(12):1078-1087. PubMed ID: 36349793
[TBL] [Abstract][Full Text] [Related]
4. Declining Lung Function and Cardiovascular Risk: The ARIC Study.
Silvestre OM; Nadruz W; Querejeta Roca G; Claggett B; Solomon SD; Mirabelli MC; London SJ; Loehr LR; Shah AM
J Am Coll Cardiol; 2018 Sep; 72(10):1109-1122. PubMed ID: 30165982
[TBL] [Abstract][Full Text] [Related]
5. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
[TBL] [Abstract][Full Text] [Related]
6. Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1.
Chambers DC; Boldy DA; Ayres JG
Respir Med; 1999 Oct; 93(10):726-33. PubMed ID: 10581662
[TBL] [Abstract][Full Text] [Related]
7. Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease.
Whittaker HR; Pimenta JM; Jarvis D; Kiddle SJ; Quint JK
Int J Chron Obstruct Pulmon Dis; 2020; 15():3079-3091. PubMed ID: 33268984
[TBL] [Abstract][Full Text] [Related]
8. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
Chien JW; Au DH; Barnett MJ; Goodman GE
COPD; 2007 Dec; 4(4):339-46. PubMed ID: 18027161
[TBL] [Abstract][Full Text] [Related]
9. A five year follow-up of lung function among chemical workers using flow-volume and impedance measurements.
Keman S; Willemse B; Wesseling GJ; Kusters E; Borm PJ
Eur Respir J; 1996 Oct; 9(10):2109-15. PubMed ID: 8902475
[TBL] [Abstract][Full Text] [Related]
10. Lifetime Risk Factors for Pre- and Post-Bronchodilator Lung Function Decline. A Population-based Study.
Bui DS; Perret JL; Walters EH; Abramson MJ; Burgess JA; Bui MQ; Bowatte G; Lowe AJ; Russell MA; Alif SM; Thompson BR; Hamilton GS; Giles GG; Thomas PS; Morrison S; Johns DP; Knibbs LD; Zock JP; Marcon A; Garcia-Aymerich J; Erbas B; Jarvis D; Svanes C; Lodge CJ; Dharmage SC
Ann Am Thorac Soc; 2020 Mar; 17(3):302-312. PubMed ID: 31800292
[No Abstract] [Full Text] [Related]
11. [Study on changes of pulmonary function in patients with pneumoconiosis in three years].
Li X; Dai WR; Liu WF; Yang ZX; Xie L; Wu ZY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Dec; 38(12):891-894. PubMed ID: 33406545
[No Abstract] [Full Text] [Related]
12. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
13. The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort.
Drummond MB; Merlo CA; Astemborski J; Kalmin MM; Kisalu A; Mcdyer JF; Mehta SH; Brown RH; Wise RA; Kirk GD
AIDS; 2013 May; 27(8):1303-11. PubMed ID: 23299176
[TBL] [Abstract][Full Text] [Related]
14. Lung Function Trajectories and Associated Mortality among Adults with and without Airway Obstruction.
Backman H; Blomberg A; Lundquist A; Strandkvist V; Sawalha S; Nilsson U; Eriksson-Ström J; Hedman L; Stridsman C; Rönmark E; Lindberg A
Am J Respir Crit Care Med; 2023 Nov; 208(10):1063-1074. PubMed ID: 37460250
[No Abstract] [Full Text] [Related]
15. Impaired lung function and lung cancer risk in 461 183 healthy individuals: a cohort study.
Kyaw TW; Tsai MK; Wen CP; Shu CC; Su TC; Wu X; Gao W
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38719501
[TBL] [Abstract][Full Text] [Related]
16. Weight gain and longitudinal changes in lung function in steel workers.
Wang ML; McCabe L; Petsonk EL; Hankinson JL; Banks DE
Chest; 1997 Jun; 111(6):1526-32. PubMed ID: 9187168
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study.
Takx RA; Vliegenthart R; Mohamed Hoesein FA; Išgum I; de Koning HJ; Mali WP; van der Aalst CM; Zanen P; Lammers JW; Groen HJ; van Rikxoort EM; Schmidt M; van Ginneken B; Oudkerk M; Leiner T; de Jong PA
Eur Radiol; 2015 Jan; 25(1):65-71. PubMed ID: 25182625
[TBL] [Abstract][Full Text] [Related]
18. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
19. Changes in lung function among treated HIV-positive and HIV-negative individuals: analysis of the prospective AGE
Verboeket SO; Boyd A; Wit FW; Verheij E; Schim van der Loeff MF; Kootstra N; van der Valk M; van Steenwijk RP; Drummond MB; Kirk GD; Reiss P;
Lancet Healthy Longev; 2021 Apr; 2(4):e202-e211. PubMed ID: 36098121
[TBL] [Abstract][Full Text] [Related]
20. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
